Corona Remedies’ IPO opened on December 8 and will close on December 10, with shares priced between ₹1,008 and ₹1,062. The ₹655.37 crore offer is entirely an offer for sale, with no fresh equity issued. Listing is expected on December 15.
Corona Remedies IPO Day 2: Check subscription status, GMP, and other details – Should you buy?
